These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31015599)

  • 1. Iron oxide nanoclusters for T
    Lu Y; Xu YJ; Zhang GB; Ling D; Wang MQ; Zhou Y; Wu YD; Wu T; Hackett MJ; Hyo Kim B; Chang H; Kim J; Hu XT; Dong L; Lee N; Li F; He JC; Zhang L; Wen HQ; Yang B; Hong Choi S; Hyeon T; Zou DH
    Nat Biomed Eng; 2017 Aug; 1(8):637-643. PubMed ID: 31015599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large-scale synthesis of uniform and extremely small-sized iron oxide nanoparticles for high-resolution T1 magnetic resonance imaging contrast agents.
    Kim BH; Lee N; Kim H; An K; Park YI; Choi Y; Shin K; Lee Y; Kwon SG; Na HB; Park JG; Ahn TY; Kim YW; Moon WK; Choi SH; Hyeon T
    J Am Chem Soc; 2011 Aug; 133(32):12624-31. PubMed ID: 21744804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. pH-responsive pHLIP (pH low insertion peptide) nanoclusters of superparamagnetic iron oxide nanoparticles as a tumor-selective MRI contrast agent.
    Wei Y; Liao R; Mahmood AA; Xu H; Zhou Q
    Acta Biomater; 2017 Jun; 55():194-203. PubMed ID: 28363789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging.
    Unterweger H; Janko C; Schwarz M; Dézsi L; Urbanics R; Matuszak J; Őrfi E; Fülöp T; Bäuerle T; Szebeni J; Journé C; Boccaccini AR; Alexiou C; Lyer S; Cicha I
    Int J Nanomedicine; 2017; 12():5223-5238. PubMed ID: 28769560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound-triggered BSA/SPION hybrid nanoclusters for liver-specific magnetic resonance imaging.
    Zhang B; Li Q; Yin P; Rui Y; Qiu Y; Wang Y; Shi D
    ACS Appl Mater Interfaces; 2012 Dec; 4(12):6479-86. PubMed ID: 23151093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical synthesis and assembly of uniformly sized iron oxide nanoparticles for medical applications.
    Ling D; Lee N; Hyeon T
    Acc Chem Res; 2015 May; 48(5):1276-85. PubMed ID: 25922976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron-oxide-based twin nanoplates with strong T
    Wei R; Zhou T; Sun C; Lin H; Yang L; Ren BW; Chen Z; Gao J
    Nanoscale; 2018 Oct; 10(38):18398-18406. PubMed ID: 30256373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticle Biokinetics in Mice and Nonhuman Primates.
    Chiarelli PA; Revia RA; Stephen ZR; Wang K; Jeon M; Nelson V; Kievit FM; Sham J; Ellenbogen RG; Kiem HP; Zhang M
    ACS Nano; 2017 Sep; 11(9):9514-9524. PubMed ID: 28885825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Citrate coated iron oxide nanoparticles with enhanced relaxivity for in vivo magnetic resonance imaging of liver fibrosis.
    Saraswathy A; Nazeer SS; Jeevan M; Nimi N; Arumugam S; Harikrishnan VS; Varma PR; Jayasree RS
    Colloids Surf B Biointerfaces; 2014 May; 117():216-24. PubMed ID: 24646453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron Oxide Nanoparticle Based Contrast Agents for Magnetic Resonance Imaging.
    Shen Z; Wu A; Chen X
    Mol Pharm; 2017 May; 14(5):1352-1364. PubMed ID: 27776215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasmall water-soluble metal-iron oxide nanoparticles as T1-weighted contrast agents for magnetic resonance imaging.
    Zeng L; Ren W; Zheng J; Cui P; Wu A
    Phys Chem Chem Phys; 2012 Feb; 14(8):2631-6. PubMed ID: 22273844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasmall Ferrite Nanoparticles Synthesized via Dynamic Simultaneous Thermal Decomposition for High-Performance and Multifunctional T
    Zhang H; Li L; Liu XL; Jiao J; Ng CT; Yi JB; Luo YE; Bay BH; Zhao LY; Peng ML; Gu N; Fan HM
    ACS Nano; 2017 Apr; 11(4):3614-3631. PubMed ID: 28371584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular imaging of activated platelets via antibody-targeted ultra-small iron oxide nanoparticles displaying unique dual MRI contrast.
    Ta HT; Li Z; Hagemeyer CE; Cowin G; Zhang S; Palasubramaniam J; Alt K; Wang X; Peter K; Whittaker AK
    Biomaterials; 2017 Jul; 134():31-42. PubMed ID: 28453956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designed synthesis of uniformly sized iron oxide nanoparticles for efficient magnetic resonance imaging contrast agents.
    Lee N; Hyeon T
    Chem Soc Rev; 2012 Apr; 41(7):2575-89. PubMed ID: 22138852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatory drug evaluation in ApoE-/- mice by ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging.
    Sigovan M; Kaye E; Lancelot E; Corot C; Provost N; Majd Z; Breisse M; Canet-Soulas E
    Invest Radiol; 2012 Sep; 47(9):546-52. PubMed ID: 22864378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased transverse relaxivity in ultrasmall superparamagnetic iron oxide nanoparticles used as MRI contrast agent for biomedical imaging.
    Mishra SK; Kumar BS; Khushu S; Tripathi RP; Gangenahalli G
    Contrast Media Mol Imaging; 2016 Sep; 11(5):350-361. PubMed ID: 27230705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid microwave-assisted synthesis of dextran-coated iron oxide nanoparticles for magnetic resonance imaging.
    Osborne EA; Atkins TM; Gilbert DA; Kauzlarich SM; Liu K; Louie AY
    Nanotechnology; 2012 Jun; 23(21):215602. PubMed ID: 22551699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular magnetic resonance imaging in small animals.
    Botnar RM; Makowski MR
    Prog Mol Biol Transl Sci; 2012; 105():227-61. PubMed ID: 22137434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of water-based ferrofluids as contrast agents for magnetic resonance imaging.
    Casula MF; Corrias A; Arosio P; Lascialfari A; Sen T; Floris P; Bruce IJ
    J Colloid Interface Sci; 2011 May; 357(1):50-5. PubMed ID: 21345440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comparative Study of Receptor-Targeted Magnetosome and HSA-Coated Iron Oxide Nanoparticles as MRI Contrast-Enhancing Agent in Animal Cancer Model.
    Erdal E; Demirbilek M; Yeh Y; Akbal Ö; Ruff L; Bozkurt D; Cabuk A; Senel Y; Gumuskaya B; Algın O; Colak S; Esener S; Denkbas EB
    Appl Biochem Biotechnol; 2018 May; 185(1):91-113. PubMed ID: 29082480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.